Your browser doesn't support javascript.
loading
SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker.
Schneider, Constantin; Raybould, Matthew I J; Deane, Charlotte M.
Afiliação
  • Schneider C; Department of Statistics, University of Oxford, Oxford, UK.
  • Raybould MIJ; Department of Statistics, University of Oxford, Oxford, UK.
  • Deane CM; Department of Statistics, University of Oxford, Oxford, UK.
Nucleic Acids Res ; 50(D1): D1368-D1372, 2022 01 07.
Article em En | MEDLINE | ID: mdl-34986602
ABSTRACT
In 2013, we released the Structural Antibody Database (SAbDab), a publicly available repository of experimentally determined antibody structures. In the interim, the rapid increase in the number of antibody structure depositions to the Protein Data Bank, driven primarily by increased interest in antibodies as biotherapeutics, has led us to implement several improvements to the original database infrastructure. These include the development of SAbDab-nano, a sub-database that tracks nanobodies (heavy chain-only antibodies) which have seen a particular growth in attention from both the academic and pharmaceutical research communities over the past few years. Both SAbDab and SAbDab-nano are updated weekly, comprehensively annotated with the latest features described here, and are freely accessible at opig.stats.ox.ac.uk/webapps/newsabdab/.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Software / Bases de Dados Genéticas / Anticorpos de Domínio Único / Anticorpos Limite: Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Software / Bases de Dados Genéticas / Anticorpos de Domínio Único / Anticorpos Limite: Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2022 Tipo de documento: Article